Bharat Biotech

Standing Technical Sub-Committee (STSC) has given a nod for the use of Biological E`s Corbevax and Bharat Biotech`s Covaxin for children aged between 5-12 years, sources informed on Friday. According to the sources, no decision on…
Read More...

The clinical phase III trials of the Bharat Biotech’s COVID-19 nasal vaccine have been completed and the company will submit its data to the Drugs Controller General of India (DCGI) next month, Dr Krishna Ella, Chairman and Managing…
Read More...

The Drugs Controller General of India (DCGI) on Friday gave its permission to Bharat Biotech for conducting trials of intranasal booster doses against the coronavirus disease (Covid-19). According to an input from news agency ANI, the…
Read More...

Ahead of Covaxin's precaution or booster dose administration to front line workers and those aged above 60, Bharat Biotech on Saturday claimed that the booster dose trial showed promising results. The trial of Covaxin booster jabs has…
Read More...

As India is witnessing a surge in cases of Omicron variant, Hyderabad-based Bharat Biotech has submitted the phase 3 clinical trial application to the Drugs Controller General of India (DCGI) to get approval for the booster dose of their…
Read More...